Angiochem pulled off the rare feat of getting an anticancer antibody through the brain’s protective mesh in a preclinical study, and now the Canadian biotech is on the hunt for partners to take the next step.

…read more

Source: Angiochem heralds preclinical promise with brain-penetrating cancer therapy


0 No comments